Cardiff Oncology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $121 | $109 | $151 | $165 |
Gross Profit | 121 | 109 | 55 | 165 |
EBITDA | -14,777 | -14,154 | -12,476 | -12,500 |
EBIT | -14,736 | -14,382 | -12,572 | -12,601 |
Net Income | -13,949 | -13,434 | -11,787 | -11,855 |
Net Change In Cash | 121 | 109 | 151 | 165 |
Free Cash Flow | -8,354 | -12,794 | -10,267 | -10,456 |
Cash | 10,784 | 24,095 | 51,470 | 13,038 |
Basic Shares | 66,526 | 47,650 | 47,650 | 46,865 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $683 | $488 | $386 | $359 |
Gross Profit | 683 | 488 | 186 | -141 |
EBITDA | -48,247 | -45,014 | -39,666 | -28,404 |
EBIT | -48,651 | -45,412 | -39,866 | -28,904 |
Net Income | -45,431 | -41,441 | -38,704 | -28,291 |
Net Change In Cash | 683 | 488 | 386 | 359 |
Cost of Revenue | 4,404 | -119,038 | ||
Free Cash Flow | -37,773 | -31,469 | -34,712 | -23,245 |
Cash | 51,470 | 21,655 | 16,347 | 11,943 |
Basic Shares | 47,650 | 44,677 | 43,600 | 39,030 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.21 |
